Status:
COMPLETED
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this exploratory study is to evaluate the effects of sertindole and olanzapine on neurocognitive functioning in patients with schizophrenia.
Detailed Description
Cognitive deficits, including impairments in areas such as memory, attention, and executive function, are major determinants and predictors of long-term disability in schizophrenia. At present, availa...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with schizophrenia
- Participation in 11286 study
- Capable of completing all study-related psychometric activities for the duration of the study
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00759421
Start Date
October 1 2006
End Date
April 1 2008
Last Update
September 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TWN001
Tapei, Taiwan, 112